Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bergmann

Showing results (121-130 of 272) with videos related to

Pageof 28
Sort By:
Annals of Hematology|March 1, 1995
Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemiaE Weidmann, J Brieger, B Jahn, et al.
Leukemia|December 1, 1994
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cellsJ Brieger, E Weidmann, K Fenchel, et al.
Onkologie|February 1, 1988
Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II studyP S Mitrou, C Fischer, D Huhn, et al.
Journal of Cellular Physiology|July 1, 1984
Analysis of pure and mixed murine mast cell coloniesP N Pharr, T Suda, K L Bergmann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot studyL Bergmann, T Karakas, A Knuth, et al.
Praxis|May 11, 1999
[Stem cell supported high dose chemotherapy (HDCT) in primary treatment of advanced ovarian carcinoma]V Möbus, C von Schilling, R Kreienberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRJ Brieger, E Weidmann, U Maurer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemiaT Karakas, U Maurer, E Weidmann, et al.
Leukemia & Lymphoma|April 28, 2000
Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemiaM Griesshammer, B Kubanek, H Beneke, et al.
Blood|August 1, 1997
High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcomeL Bergmann, C Miething, U Maurer, et al.
Pageof 28

Showing results (121-130 of 272) with videos related to

Sort By:
Pageof 28
Annals of Hematology|March 1, 1995
Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemiaE Weidmann, J Brieger, B Jahn, et al.
Leukemia|December 1, 1994
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cellsJ Brieger, E Weidmann, K Fenchel, et al.
Onkologie|February 1, 1988
Treatment of advanced, progressive epidemic Kaposi's sarcoma (EKS): a phase-II studyP S Mitrou, C Fischer, D Huhn, et al.
Journal of Cellular Physiology|July 1, 1984
Analysis of pure and mixed murine mast cell coloniesP N Pharr, T Suda, K L Bergmann, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot studyL Bergmann, T Karakas, A Knuth, et al.
Praxis|May 11, 1999
[Stem cell supported high dose chemotherapy (HDCT) in primary treatment of advanced ovarian carcinoma]V Möbus, C von Schilling, R Kreienberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCRJ Brieger, E Weidmann, U Maurer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1998
High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemiaT Karakas, U Maurer, E Weidmann, et al.
Leukemia & Lymphoma|April 28, 2000
Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemiaM Griesshammer, B Kubanek, H Beneke, et al.
Blood|August 1, 1997
High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcomeL Bergmann, C Miething, U Maurer, et al.
Pageof 28